This medical supplies distributor raised its 2025 earnings outlook on Monday. Cencora stock is near a buy point of a newly formed base. Cencora (NYSE:COR) has made headlines with its announcement ...

Cencora stock hit a buy point of a newly formed flat base Tuesday morning, after the medical supplies and distribution company raised its fiscal 2025 earnings outlook for the second time in two ...

Cencora, Inc. (NYSE:COR – Get Free Report) reached a new 52-week high during mid-day trading on Tuesday . The company traded as high as $280.70 and last traded at $278.17, with a volume of ...

Cencora has gained 20.8% since the start of the year compared to the 2.8% move for the Zacks Medical sector and the 5% return for the Zacks Medical Services industry. The stock has a great record ...

Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution ...

Cencora has gained 16.4% since the start of the year compared to the 4.9% move for the Zacks Medical sector and the 3% return for the Zacks Medical Services industry. The stock has a great record ...

Alto and Cencora are collaborating to deliver enhanced patient support services and streamline access to prescribed specialty medications. The collaboration leverages Cencora’s patient support ...

StockNews.com upgraded shares of Cencora ... equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical ...